COVID-19 pandemic
The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients.
Sources: The Independent
Changes
- The Medicines and Healthcare products Regulatory Agency approved the use of the Pfizer's anti-viral oral drug Paxlovid for people who are high risk from developing serious disease and death.
- The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients.